GENERATION BIO CO's ticker is GBIO and the CUSIP is 37148K100. A total of 98 filers reported holding GENERATION BIO CO in Q2 2021. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $270,508 | -31.1% | 71,377 | -0.1% | 0.00% | – |
| Q2 2023 | $392,854 | +121904.3% | 71,428 | -4.7% | 0.00% | – |
| Q1 2023 | $322 | +10.3% | 74,912 | +0.8% | 0.00% | – |
| Q4 2022 | $292 | -99.9% | 74,331 | +5.2% | 0.00% | -100.0% |
| Q3 2022 | $375,000 | -11.8% | 70,662 | +9.1% | 0.00% | 0.0% |
| Q2 2022 | $425,000 | +31.2% | 64,777 | +46.7% | 0.00% | – |
| Q1 2022 | $324,000 | +4.2% | 44,156 | +0.6% | 0.00% | – |
| Q4 2021 | $311,000 | -72.5% | 43,877 | -2.7% | 0.00% | -100.0% |
| Q3 2021 | $1,131,000 | -2.5% | 45,105 | +4.6% | 0.00% | 0.0% |
| Q2 2021 | $1,160,000 | -3.4% | 43,135 | +2.2% | 0.00% | 0.0% |
| Q1 2021 | $1,201,000 | +209.5% | 42,195 | +208.0% | 0.00% | +100.0% |
| Q4 2020 | $388,000 | +11.8% | 13,700 | +22.0% | 0.00% | 0.0% |
| Q3 2020 | $347,000 | – | 11,232 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Atlas Venture Life Science Advisors, LLC | 8,278,876 | $54,309,000 | 9.08% |
| Artal Group S.A. | 2,814,191 | $18,461,000 | 0.99% |
| HighVista Strategies LLC | 248,994 | $1,633,000 | 0.99% |
| Yiheng Capital Management, L.P. | 2,597,631 | $17,040,000 | 0.97% |
| PFM Health Sciences, LP | 2,773,313 | $18,193,000 | 0.69% |
| BVF INC/IL | 1,556,032 | $10,273,000 | 0.50% |
| HARVARD MANAGEMENT CO INC | 510,354 | $3,348,000 | 0.39% |
| Bellevue Group AG | 3,627,280 | $23,795,000 | 0.34% |
| FARALLON CAPITAL MANAGEMENT LLC | 2,897,300 | $19,006,000 | 0.10% |
| Corton Capital Inc. | 15,493 | $102,000 | 0.10% |